hrp0082lbp-d3-1005 | (1) | ESPE2014
De Schepper Jean
, Vanderfaeillie Johan
, Mullis Primus-E
, Rooman Raoul
, Matthews Lisa
, Dilleen Maria
, Browning Richard
, Gomez Roy
, Wollmann Hartmut
Background: There are limited data available on the efficacy and safety of GH treatment in very young (<30 months) short children, born small for gestational age (SGA).Objectives: To determine the effect of 24 months of GH treatment on body height, BMI, and head growth as well as overall psychomotor development (using the Bayley Scale of Infant Development (BSID-II)) and demonstrate its safety in young (aged between 19 and 29 months) short SGA childr...